CERUS CORP Logo

CERUS CORP

Develops pathogen inactivation technology to reduce transfusion-transmitted infections.

CERS | US

Overview

Corporate Details

ISIN(s):
US1570851014
LEI:
Country:
United States of America
Address:
1220 CONCORD AVENUE, 94520 CONCORD

Description

Cerus Corporation is a biomedical products company dedicated to safeguarding the world's blood supply. The company develops and commercializes the INTERCEPT Blood System, a pathogen inactivation technology designed to reduce the risk of transfusion-transmitted infections. The system inactivates a broad spectrum of viruses, bacteria, parasites, and leukocytes in donated blood components. It is used for platelets and plasma, with a system for red blood cells in development. Cerus provides its technology to blood centers and hospitals, aiming to establish a new standard of care for blood safety.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 22:07
4
English 6.5 KB
2025-11-24 23:17 English 7.4 KB
2025-11-14 22:24 English 10.4 KB
2025-11-06 23:01
10-Q
English 2.0 MB
2025-11-06 22:03
8-K
English 218.7 KB
2025-08-25 21:25
4
English 6.4 KB
2025-08-14 22:26 English 10.4 KB
2025-08-05 23:24
S-8
English 66.1 KB
2025-08-05 22:52
10-Q
English 2.1 MB
2025-08-05 22:02
8-K
English 221.5 KB
2025-07-30 19:21 English 11.0 KB
2025-06-23 22:32
8-K
English 11.4 KB
2025-06-09 19:39
8-K
English 55.6 KB
2025-06-05 00:53
4
English 7.0 KB
2025-06-05 00:48
4
English 7.1 KB

Automate Your Workflow. Get a real-time feed of all CERUS CORP filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CERUS CORP

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CERUS CORP via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.